Detalhe da pesquisa
1.
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
Eur J Haematol
; 111(5): 815-823, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574220